India · Delayed Price · Currency is INR Senores Pharmaceuticals Statistics
Total Valuation
BOM:544319 has a market cap or net worth of INR 63.95 billion. The enterprise value is 66.08 billion.
| Market Cap | 63.95B |
| Enterprise Value | 66.08B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.01% |
| Shares Change (QoQ) | +17.21% |
| Owned by Insiders (%) | 32.59% |
| Owned by Institutions (%) | 12.43% |
| Float | 21.15M |
Valuation Ratios
The trailing PE ratio is 50.21 and the forward PE ratio is 36.96.
| PE Ratio | 50.21 |
| Forward PE | 36.96 |
| PS Ratio | 9.40 |
| PB Ratio | 6.63 |
| P/TBV Ratio | 11.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 103.06 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 51.88 |
| EV / Sales | 9.71 |
| EV / EBITDA | 34.18 |
| EV / EBIT | 41.79 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 1.77 |
| Debt / FCF | -1.69 |
| Interest Coverage | 5.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.48% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 18.49M |
| Profits Per Employee | 3.46M |
| Employee Count | 368 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544319 has paid 412.70 million in taxes.
| Income Tax | 412.70M |
| Effective Tax Rate | 23.84% |
Stock Price Statistics
The stock price has increased by +93.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +93.30% |
| 50-Day Moving Average | 1,421.82 |
| 200-Day Moving Average | 1,078.55 |
| Relative Strength Index (RSI) | 48.48 |
| Average Volume (20 Days) | 39,953 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544319 had revenue of INR 6.80 billion and earned 1.27 billion in profits. Earnings per share was 28.30.
| Revenue | 6.80B |
| Gross Profit | 4.24B |
| Operating Income | 1.58B |
| Pretax Income | 1.73B |
| Net Income | 1.27B |
| EBITDA | 1.93B |
| EBIT | 1.58B |
| Earnings Per Share (EPS) | 28.30 |
Balance Sheet
The company has 1.60 billion in cash and 3.42 billion in debt, with a net cash position of -1.82 billion.
| Cash & Cash Equivalents | 1.60B |
| Total Debt | 3.42B |
| Net Cash | -1.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.65B |
| Book Value Per Share | 235.10 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 620.50 million and capital expenditures -2.65 billion, giving a free cash flow of -2.03 billion.
| Operating Cash Flow | 620.50M |
| Capital Expenditures | -2.65B |
| Depreciation & Amortization | 352.23M |
| Net Borrowing | 20.00M |
| Free Cash Flow | -2.03B |
| FCF Per Share | n/a |
Margins
Gross margin is 62.37%, with operating and profit margins of 23.25% and 18.72%.
| Gross Margin | 62.37% |
| Operating Margin | 23.25% |
| Pretax Margin | 25.44% |
| Profit Margin | 18.72% |
| EBITDA Margin | 28.42% |
| EBIT Margin | 23.25% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544319 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.01% |
| Shareholder Yield | -15.01% |
| Earnings Yield | 1.99% |
| FCF Yield | -3.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:544319 is 1,613.60, which is 16.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,613.60 |
| Price Target Difference | 16.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 33.70% |
| EPS Growth Forecast (3Y) | 35.52% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |